These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28704767)

  • 1. Ibudilast may improve attention during early abstinence from methamphetamine.
    Birath JB; Briones M; Amaya S; Shoptaw S; Swanson AN; Tsuang J; Furst B; Heinzerling K; Obermeit L; Maes L; McKay C; Wright MJ
    Drug Alcohol Depend; 2017 Sep; 178():386-390. PubMed ID: 28704767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study.
    Worley MJ; Swanson A-N; Heinzerling KG; Roche DJ; Shoptaw S
    Drug Alcohol Depend; 2016 May; 162():245-50. PubMed ID: 26993372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
    Heinzerling KG; Briones M; Thames AD; Hinkin CH; Zhu T; Wu YN; Shoptaw SJ
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):238-248. PubMed ID: 31820289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment.
    DeYoung DZ; Heinzerling KG; Swanson AN; Tsuang J; Furst BA; Yi Y; Wu YN; Moody DE; Andrenyak DM; Shoptaw SJ
    J Clin Psychopharmacol; 2016 Aug; 36(4):347-54. PubMed ID: 27269956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence.
    Pocuca N; Young JW; MacQueen DA; Letendre S; Heaton RK; Geyer MA; Perry W; Grant I; Minassian A;
    Drug Alcohol Depend; 2020 Oct; 215():108245. PubMed ID: 32871507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P300 event-related potential in abstinent methamphetamine-dependent patients.
    Haifeng J; Wenxu Z; Hong C; Chuanwei L; Jiang D; Haiming S; Zhikang C; Din X; Jijun W; Min Z
    Physiol Behav; 2015 Oct; 149():142-8. PubMed ID: 26051625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
    Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AULA virtual reality test as an attention measure: convergent validity with Conners' Continuous Performance Test.
    Díaz-Orueta U; Garcia-López C; Crespo-Eguílaz N; Sánchez-Carpintero R; Climent G; Narbona J
    Child Neuropsychol; 2014; 20(3):328-42. PubMed ID: 23638628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: a diffusion tensor imaging study.
    Salo R; Nordahl TE; Buonocore MH; Natsuaki Y; Waters C; Moore CD; Galloway GP; Leamon MH
    Biol Psychiatry; 2009 Jan; 65(2):122-8. PubMed ID: 18814867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use.
    Chen YC; Wang LJ; Lin SK; Chen CK
    Subst Use Misuse; 2015; 50(14):1778-85. PubMed ID: 26625283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.
    Marquine MJ; Iudicello JE; Morgan EE; Brown GG; Letendre SL; Ellis RJ; Deutsch R; Woods SP; Grant I; Heaton RK;
    Psychiatry Res; 2014 Jan; 215(1):208-16. PubMed ID: 24290100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users.
    Chen YC; Chen CK; Wang LJ
    J Psychoactive Drugs; 2015; 47(4):317-24. PubMed ID: 26267045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence.
    Brensilver M; Heinzerling KG; Swanson AN; Shoptaw SJ
    Exp Clin Psychopharmacol; 2012 Oct; 20(5):430-5. PubMed ID: 22867036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.
    Rezaei F; Emami M; Zahed S; Morabbi MJ; Farahzadi M; Akhondzadeh S
    Daru; 2015 Jan; 23(1):2. PubMed ID: 25588930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label pilot study of risperidone in the treatment of methamphetamine dependence.
    Meredith CW; Jaffe C; Yanasak E; Cherrier M; Saxon AJ
    J Psychoactive Drugs; 2007 Jun; 39(2):167-72. PubMed ID: 17703711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported attentional and motor impulsivity are related to age at first methamphetamine use.
    Cservenka A; Ray LA
    Addict Behav; 2017 Feb; 65():7-12. PubMed ID: 27701027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology.
    Jaffe C; Bush KR; Straits-Troster K; Meredith C; Romwall L; Rosenbaum G; Cherrier M; Saxon AJ
    J Addict Dis; 2005; 24(3):133-52. PubMed ID: 16186089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
    Hester R; Lee N; Pennay A; Nielsen S; Ferris J
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):489-97. PubMed ID: 21186923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence.
    Cook R; Quinn B; Heinzerling K; Shoptaw S
    Addiction; 2017 Jun; 112(6):1077-1085. PubMed ID: 28107598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.